Stock 6677 ANXO PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Anxo Pharmaceutical Co., Ltd.

Equities

6677

TW0006677008

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 18:00:00 2024-06-25 EDT 		5-day change 1st Jan Change
43.15 TWD +1.41% Intraday chart for Anxo Pharmaceutical Co., Ltd. -1.37% -11.31%
04-30 Anxo Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Anxo Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Business Summary

Anxo Pharmaceutical Co., Ltd is a Taiwan-based company engaged in the development and application of special pharmaceutical technology platforms and the development, manufacture and sale of special generic drugs. The Company is involved in the research and development of niche-type technology platforms and products with high-tech thresholds and high barriers to entry, as well as the provision of contract development and manufacturing organization (CDMO) services for pharmaceutical companies at home and abroad. The Company’s main operating revenues are from the sale of products, technical services, as well as original equipment manufacturer (OEM) services.

Sales per Business

TWD in Million2022Weight2023Weight Delta
Western Medicine Development and Marketing
56.9 %
494 57.0 % 535 56.9 % +8.40%
Western Medicine Manufacturing
43.1 %
373 43.0 % 405 43.1 % +8.65%

Sales per region

TWD in Million2022Weight2023Weight Delta
Taiwan
67.3 %
562 64.9 % 632 67.3 % +12.52%
Europe
15.7 %
137 15.8 % 148 15.7 % +7.68%
Singapore
14.8 %
139 16.0 % 139 14.8 % +0.33%
China
2.1 %
27 3.1 % 19 2.1 % -29.23%
Others
0.1 %
1 0.1 % 1 0.1 % +41.05%
Japan
0.1 %
1 0.1 % 1 0.1 % -11.15%

Managers

Managers TitleAgeSince
Chih Hsien Chen DFI
 Director of Finance/CFO - 15-09-30
Lin Chuan Yan BRD
 Director/Board Member - 12-12-31

Members of the board

Members of the board TitleAgeSince
Chung Cheng Chen BRD
 Director/Board Member - 18-05-22
Kuang Yang Hsu BRD
 Director/Board Member - 18-05-22
Chien Chih Wang CHM
 Chairman - 12-12-31
Lin Chuan Yan BRD
 Director/Board Member - 12-12-31
Shu Chun Chen BRD
 Director/Board Member - 17-06-26
Chih Liang Lin BRD
 Director/Board Member - 18-05-22
Chun Cheng Chen BRD
 Director/Board Member - 18-05-22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 55,664,000 55,106,865 ( 99.00 %) 0 99.00 %

Company contact information

Anxo Pharmaceutical Co., Ltd.

8/F, Lane 3, Section 2 No. 206 Nanjing East Road

104 44, Taipei

+

http://www.anxo.com.tw
address Anxo Pharmaceutical Co., Ltd.(6677)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
ANXO PHARMACEUTICAL CO., LTD. Stock Anxo Pharmaceutical Co., Ltd.
-11.31% 73.66M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+54.61% 811B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+44.25% 640B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.62% 333B
ABBVIE INC. Stock AbbVie Inc.
+10.44% 302B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.45% 246B
ROCHE HOLDING AG Stock Roche Holding AG
+2.09% 225B
NOVARTIS AG Stock Novartis AG
+13.03% 218B
AMGEN INC. Stock Amgen Inc.
+8.61% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 6677 Stock
  4. Company Anxo Pharmaceutical Co., Ltd.